Skip to main content
. Author manuscript; available in PMC: 2024 May 14.
Published in final edited form as: Clin Cancer Res. 2023 Nov 14;29(22):4549–4554. doi: 10.1158/1078-0432.CCR-23-2222

Figure 1. Schematic of the randomized trial of cellular therapy for ARDS in COVID-19.

Figure 1.

Patients were randomly assigned to different doses of cellular therapy or standard of care.